Extrapulmonary tuberculosis among females in South Asia—gap analysis  by Mehraj, Jaishri et al.
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 5 ( 2 0 1 6 ) 3 9 2 –3 9 9
.sc iencedi rect .comAvai lab le at wwwScienceDirect
journal homepage: www.elsev ier .com/ locate / IJMYCOFull Length ArticleExtrapulmonary tuberculosis among females in
South Asia—gap analysishttp://dx.doi.org/10.1016/j.ijmyco.2016.09.054
2212-5531/ 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
* Corresponding author. Department of Pathology & Laboratory Medicine, Aga Khan University Hospital, Stadium Road, PO
Karachi 74800, Pakistan.
E-mail address: rumina.hasan@aku.edu (R. Hasan).
Peer review under responsibility of Asian African Society for Mycobacteriology.Jaishri Mehraj a,b, Zain Yar Khan c, Dania Khalid Saeed d, Sadia Shakoor d,
Rumina Hasan d,*
aWorld Health Organization, Regional Country Office, Islamabad, Pakistan
b Polio Eradication and Immunization Cell, Emergency Operations Center (EOC) Sindh, Karachi, Pakistan
cAga Khan University Medical College, Karachi, Pakistan
dDepartment of Pathology & Laboratory Medicine, Aga Khan University Hospital, Karachi, PakistanA R T I C L E I N F O
Article history:
Received 31 August 2016
Accepted 4 September 2016
Available online 15 November 2016
Keywords:
Tuberculosis
Females
Female:male ratio
South AsiaA B S T R A C T
The percentage of extrapulmonary tuberculosis (EPTB) among new and relapse tuberculo-
sis cases in South Asia (Afghanistan, Pakistan, India, and Bangladesh) ranged from 19% to
23% in 2014. While tuberculosis was reportedly more prevalent in males, a higher prepon-
derance of EPTB was observed in females. National tuberculosis control programs are
highly focused on pulmonary tuberculosis. This creates gaps in the surveillance, diagnosis,
and study of EPTB among females, which is especially pronounced in the South Asian set-
ting. We have reviewed recently published literatures from January 2010 to June 2016
reporting EPTB in females with a view to evaluate the current epidemiology, risk factors,
diagnostic modalities, and treatment outcomes. We report significant gaps in the surveil-
lance of EPTB among women in South Asia, emphasizing the need for greater focus on EPTB
in females to overcome current surveillance and knowledge gaps.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Globally, tuberculosis (TB) is among the top five killers of
women aged 20–59 years [1]. While the proportion of pul-
monary TB (PTB) notifications is higher among males world-
wide, TB in females remains a major threat to control due
to the impact felt by households, particularly children. It
has been argued that the higher case notifications amongmales may reflect the barriers faced by the female population
in accessing health care [2]. Extrapulmonary tuberculosis
(EPTB) accounted for 15% of the new and relapse TB cases
in 2014 [3]. In contrast to PTB, preponderance for EPTB is
reportedly higher among females [4–6]. Irrespective of
whether the underlying mechanism is biological, socioeco-
nomic, or cultural, a deeper understanding of the risk factors,
impact, access to directly observed therapy (DOT), as well asBox 3500,
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devise effective control strategies. This is imperative as the
millennium development goals, despite achieving progress,
faltered in addressing gender disparity, in assessing impact
of TB on maternal mortality, and/or indeed in TB control,
especially in South Asia [5].
Among the South Asian countries, Pakistan, India, and
Bangladesh are included in the category of high-burden coun-
tries for TB and MDR (Multidrug resistant) TB [6]. Although
post 2015, Afghanistan is not included in high-burden coun-
tries; it has the second highest TB burden in World Health
Organization’s Eastern Mediterranean Region [3].
In keeping with the stalled progress of Millennium Devel-
opment Goals 3, 5, and 6 (i.e., reducing gender disparity,
decreasing maternal mortality, and decreasing the TB bur-
den), efforts to control EPTB among women in South Asia
need to be reassessed to identify the gaps in knowledge
and/or services. In this review, we aimed at assessing the
extent of gender disparity in EPTB in Afghanistan, Pakistan,
India, and Bangladesh through researching published litera-
tures over the past 6 years. We further sought to determine
the organ systems affected and assess outcome data for EPTB
in women available from South Asia, as well as evaluate the
utility of diagnostic modalities used for EPTB in high-TB-
burden countries of South Asian region. The search results
are presented, and the resulting information gaps are
highlighted.
Methods
Search strategy
A PubMed systematic literature search was performed for
English-language articles related to EPTB among females in
South Asia, published between January 2010 and June 2016.
Unpublished and ongoing studies could not be explored in
this review. We used the following terms in our search, indi-
vidually as well as in various combinations: tuberculosis
women, females, Pakistan, Afghanistan, India, Bangladesh,
extrapulmonary, genitourinary, infertility, postpartum, pla-
centa, Asherman syndrome, peritoneal, tubo-ovarian, and
endometrium. Two independent reviewers (J.M. and Z.Y.K.)
reviewed the titles, abstracts, and full-text articles, and
selected potentially relevant studies based on inclusion crite-
ria established prior to the literature search. Discrepancies
arising between the reviewers were resolved by consensus
in consultation with a third reviewer (R.H.).
Inclusion criteria
We included observational studies including case series, sur-
veys, and descriptive cross-sectional studies focusing on EPTB
and PTB among females in specified South Asian countries.
Exclusion criteria
We excluded all studies focusing only on diagnostic criteria,
clinical trials on drugs, case reports or case series without
details of EPTB and PTB, and articles focusing only on geneticanalysis and nonhuman studies. Studies that were conducted
in countries other than the specified countries of the Asian
region were also excluded.
Outcomes of interest
Reported cases of EPTB among males and females, female:-
male ratio (FMR) in reported studies, site of EPTB in females,
and diagnostic modalities used for diagnosis of different
types of EPTB were evaluated as outcomes in the review. We
also reviewed studies on PTB published in the same time per-
iod, in order to compare between FMRs of EPTB and PTB.Results
Search results and studies selected for review
A total of 31 studies on PTB and EPTB (published during 2010–
2016) were selected for review. Among these studies, 11 pre-
sented data on PTB, 13 presented data on EPTB, while seven
reported data on both PTB and EPTB. All seven studies pro-
vided proportions for both EPTB and PTB, but only two studies
reported separate data on EPTB and PTB for both males and
females [9,10]. Among the 20 EPTB studies reviewed, 19 stud-
ies reported on EPTB in females; 12 were from India, five from
Pakistan, and one each from Afghanistan and Bangladesh.
Among 18 studies reporting on PTB, one was from Bangla-
desh, eight were from India, and nine were from Pakistan.
The overall selection process and characteristics of the
excluded studies are summarized in Fig. S1. Excluded studies
are listed together with the reason for exclusion in the
Table S1.Study sample characteristics
All 19 studies on EPTB were conducted in health care settings
(hospitals, clinics, diagnostic centers, etc.), and in 10 studies
data were extracted from hospital records. Age ranges for
patients in these studies varied from 15 years to 70 years.
The total numbers of patients were 8,829 (ranging from amin-
imum of 37 to a maximum of 1,994) in these studies. Charac-
teristics of the studies included in this review are
summarized in Table 1.
Table S2 presents details of studies reporting on PTB,
which were also reviewed for comparison of FMRs in PTB with
EPTB. Compared with PTB studies, sample sizes were smaller
for EPTB studies.Types of EPTB among females
Six studies reported distribution of EPTB according to disease
sites among females. Among these, only two studies reported
various types of EPTB [20,11], while the other four [9,19–21]
were based on gender-specific cohorts of women tested for
or diagnosed with infertility. Of the two studies reporting on
distribution by site, TB adenitis was the commonest form, fol-
lowed by pleural TB, central nervous system TB, muscu-
loskeletal (bone) TB, and abdominal TB.
Table 1 – Summary of characteristics of the studies included in the review and proportion of extrapulmonary tuberculosis among participants in South Asia (Afghanistan,
Bangladesh, India, and Pakistan).
Author & year of publication Country Type of study Study population & settings Sample size (no.
of EPTB)
Types of EPTB (%) FMRa
Fader et al., 2010 [8] Afghanistan Retrospective review of records EPTB patients diagnosed at local
hospital
118 (118) Lymph node (37.3%), CNS
(20.3%), skeletal (11.9%), pleural
(8.5%), abdominal (6.8%),
genitourinary (5.1%), others
(10.1%)
2
Miah et al., 2011 [9] Bangladesh Cross-sectional study Abdominal TB patients 53 (53) Abdominal TB 0.6
Sharma et al., 2010 [10] India Retrospective review of the records Women who underwent
laparoscopy for infertility
313 (87) Genital TB —
Mukherjee et al., 2012 [11] India Retrospective record review TB patients registered under
RNTCP in Nadia, West Bengal
3,605 (335) — 0.8
Rana et al., 2011 [12] India Cross-sectional study Women presenting to infertility
clinics
143 (34) Genital TB —
Sharma et al., 2011 [13] India Retrospective case series Women undergoing vaginal
hysterectomy
70 (7) Genital TB —
Kohli et al., 2011 [14] India Cross sectional study Women attending infertility
clinic of hospital
100 (13) Genital TB —
Maurya et al., 2012 [15] India Prospective observational study Specimen of EPTB patients
submitted from two tertiary care
centers
756 (165) Not specified 0.8
Banerjee et al., 2012 [16] India Prospective case–control study Women with ectopic pregnancy
or spontaneous miscarriage
37 (7) Genital TB —
Prakasha et al., 2013 [17] India Retrospective record-based study Registered TB patients for DOTs
treatment in hospital
1,267 (528) Pleural TB (28.03%), lymph node
(24.81%), abdomen (9.66%), CNS
(12.50%), bones and joints
(12.31%), others (12.69%)
0.9
Das et al., 2014 [18] India Retrospective cohort study TB patients of all age groups in
Nagaland hospitals
238 (29) Not specified —
Samant et al., 2014 [19] India Retrospective review of records Patients of diagnosed with
abdominal TB in a hospital
61 (61) Abdominal TB 1.7
Awasthi, 2015 [20] India Retrospective review of records Patients diagnosed with
abdominal TB in a hospital
48 (48) Abdominal TB 0.7
Sarpal et al., 2015 [7] India Cohort study Patients registered under RNTCP
category II
545 (115) Not specified 0.95
Singh et al., 2016 [21] India Prospective study All patients with tuberculous
peripheral lymphadenitis at a
diagnostic center
255 (204) Tuberculous lymphadenopathy 1.4
Dusthackeer et al., 2015 [22] India Review of laboratory records Samples submitted for culture 1,295 (189) CSF (5.3%), renal (9%),
endometrial (1.6%), lymph node
(30.7%), unknown (53.4)
—
Chandir et al., 2010 [23] Pakistan Retrospective case series All patients diagnosed or treated
for EPTB
194 (194) Pleural TB (1.0%), lymph node
(35.6%), abdomen (9.3%), CNS
(9.3%), musculoskeletal and
others (9.3%)
2.9
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The proportion of women with EPTB in the studies reviewed
was in the range of 10–74.7%. The FMR was 0.6–2.9. Of the
19 studies included, 10 provided data on FMRs in EPTB. These
studies suggest that FMR varies with higher ratios toward the
western part of the region: 1.9–2.9 in Afghanistan and Pak-
istan versus 0.6–1.7 in India and Bangladesh.
The analysis also aimed at evaluating whether there were
any reported gender-associated differences among sites of
EPTB. FMR in EPTB by site of involvement of organs is pre-
sented in Table S3. Most studies showed a slightly greater
incidence of abdominal TB in males as compared with
females, while central nervous system, pleural, and cuta-
neous TB were present in an equal proportion among both
genders. The literature reviewed reported more dominance
of lymph node, bone, pericardial, breast, genitourinary, and
miliary TB in females as compared with males.
In contrast, PTB was more common in males than in
females. However, the FMR varied by study and geographical
location (Fig. S2).
Risk factors
Although a number of studies documented socioeconomic
factors in EPTB cases, none explored risk factors for TB and/
or for EPTB in women. Where presented, a history of contact
or Mantoux test results were not analyzed separately for
females or those affected by TB among a cohort, or for EPTB.
Diagnostic modalities
Diagnostic modalities most relied upon for diagnosis of EPTB
were histopathology followed by microscopy. In histopathol-
ogy, presence of granuloma was frequently taken as evidence
of TB. Extent of testing to exclude other etiologies presenting
as granulomas was discussed in only one instance where the
authors cited insufficient facilities to exclude other etiologies
[8]. Table 2 presents the combinations of various diagnostic
modalities used in reviewed studies.
The use of adenine deaminase activity was reported in one
study [9], whereas the use of radiological evidence was
included in five studies.
DOT coverage
Although seven of 18 studies reporting EPTB were from
program-related sites [9,10,20,21,27–29], they did not report
on DOT coverage among females affected by EPTB. Themajor-
ity of the remaining 11 studies were from tertiary care facili-
ties or advanced diagnostic centers (mainly for infertility) that
did not reveal links with DOT programs.
Treatment outcome
Outcome data on EPTB were scanty, although poorer out-
comes for EPTB as compared with PTB were reported in one
study albeit without gender disaggregated rates [18], while
another reported no difference by gender in EPTB outcomes
Table 2 – Investigative modalities used in research studies to diagnose EPTB in females, 2010–2016.
Reference Presentation Diagnostic
modality used
Clinical TST Radiological Histopathology Bacteriological Others
Sharma et al. [10] Women undergoing laparoscopy Laparoscopic findings   + Microscopy/culture
Chandir et al. [23] EPTB (mixed) +  X-ray + Microscopy/culture CSF analysis
Fader et al. [8] EPTB (n = 118) +  X-ray + (granulomas)  Body fluid analysis
Kohli et al. [14] Infertility with endometritis   + (granulomas) Microscopy/
culture PCR
IgG to 38 kDa Ag
Miah et al. [9] Abdominal TB Endoscopy, laparoscopy,
laparotomy
+ X-ray, ultrasound/
barium/CT scans
FNA/biopsy Microscopy ADA Ascitic
fluid examination
Sharma et al. [13] Vaginal hysterectomy    +  
Rana et al. [12] Infertility    + Microscopy/culture
Maurya et al. [15] MTB isolates from EPTB patients     Culture
Banerjee et al. [16] Ectopic pregnancy    + Culture
Batra et al. [24] EPTB in children + X-ray
Samant et al. [19] Abdominal TB Response to therapy   + (granuloma) Microscopy/culture
Awasthi [20] Abdominal TB Response to ATT + X-ray + (granuloma) Microscopy/culture
Dusthackeer et al. [22] EPTB suspects  Culture
Singh and Tiwari [21] Lymphadenitis Response to treatment FNAC/biopsy
(granuloma/necrosis)
Microscopy
Note: ADA = adenine deaminase activity; ATT = antitubercular treatment; CSF = cerebrospinal fluid; CT = computed tomography; CSF = cerebrospinal fluid; EPTB = extrapulmonary tuberculosis;
FNA = fine needle aspiration; FNAC = fine needle aspiration cytology; PCR = polymerase chain reaction; TB = tuberculosis; TST = tuberculin skin test; + = positive;  = negative.
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females with genital TB [10,13].
Gap analysis
From the body of literature published during 2010–2016, gaps
were identified in a number of areas in EPTB among females.
Table 3 presents gap analysis results comparing available data
with gaps in the information, knowledge, or surveillance
required to inform epidemiology of, risk factors for, diagnostic
needs for, and treatment outcomes for EPTB among females
in South Asia.
Discussion
From 2010 to mid-2016, research into EPTB among females in
the South Asian countries of Afghanistan, Pakistan, India,
and Bangladesh has not informed current epidemiology of
TB. While several factors may be responsible for research
studies falling short of this requirement (including funding,
research capacity, and infrastructure), gender- and age-
disaggregated data by site have also not been provided by
the world TB reports published annually by the World Health
Organization. This surveillance gap comprises the first of the
many hurdles in understanding EPTB among females. The
lack of robust diagnostic modalities for EPTB further widens
these surveillance gaps. The advent of Xpert MTB/RIF (Cep-
heid, Sunnyvale, California, USA) test as an effective diagnos-
tic test for EPTB [28] is expected to improve the diagnostic
landscape. Future assessments of EPTB among females
should, therefore, use advanced molecular tests as part of
the algorithm used to establish the diagnosis of EPTB.
Although significant progress has been made in strengthen-
ing the national TB program surveillance systems in case
notifications and recording treatment outcomes in all four
countries [3], gender stratified treatment outcome data on
EPTB are not routinely recorded or presented. What follows
is an unmet information gap in the factors associated (includ-
ing resistance rates) with treatment failures among females
with EPTB. These are important, as sequelae of EPTB among
women of reproductive age group (except in TB adenitis) are
associatedwith significant morbidity and evenmore seriously
felt in maternal EPTB through impact on perinatal morbidity
and mortality [29].
Other notable gaps include the lack of knowledge regard-
ing EPTB risk factors among females. This is especially sig-
nificant in view of the high FMRs in Afghanistan and
western Pakistan, suggesting genetic predisposition to EPTB
among indigenous ethnic populations. Moreover, diabetes
and malnutrition, which are known risk factors for TB
[30,31], are also highly prevalent among females in South
Asia [32,33], but have not been analyzed as risk factors for
EPTB.
Finally, the overarching gap is in the engagement of multi-
site health care providers in South Asia, as observed by lim-
ited integration of public private partnerships in study
designs. The surveillance and knowledge gaps reinforce the
importance of overcoming these gaps thorough collaboration
with private health care providers to enhance surveillance
and develop well-designed and large-scale research studies.
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There is a need to focus on EPTB among female populations to
document the epidemiology in South Asia, and examine the
risk factors, diagnostic modalities, treatment strategies, and
outcomes to carry out preventive and control measures.
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